Home・Listă Acțiuni・Twist Bioscience Corp

Twist Bioscience Corp

Închisă

SectorSănătate

108.46 -5

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

108.24

Maxim

114.17

Indicatori cheie
By Trading Economics
Venit	9M -35M
Vânzări	7.7M 118M
EPS	-0.56
Marjă de profit	-29.61
Angajați	979
EBITDA	1.5M -36M

Recomandări
By TipRanks
Recomandări	Puternic Cumpărare
Prognoză pe 12 luni	-4.46% downside

Statistici piață
By TradingEconomics
Capitalizare de piață	2.8B 6.3B
Deschiderea anterioară	113.46
Închiderea anterioară	108.46

Sentimentul știrilor

By Acuity

69%

31%

306 / 340 Clasament în Healthcare

Twist Bioscience Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

5 aug. 2026, 23:56 UTC

Twist Bioscience Corp shares rose in after-market trading, despite earlier declines. Market sentiment was affected by a disappointing ADP employment report.

4 aug. 2026, 23:01 UTC

News

Twist Bioscience announced a $250 million public offering, raising concerns over potential dilution. Shares are trading lower in after-market hours following the announcement.

3 aug. 2026, 22:16 UTC

Twist Bioscience Corp shares are lower in after-market hours, despite an initial gain following Monday's close. No specific news was identified to explain the decline.

31 iul. 2026, 19:56 UTC

Twist Bioscience shares are higher, reflecting positive sentiment in biotechnology amid strong results from major technology firms like Amazon.

30 iul. 2026, 10:16 UTC

Twist Bioscience Corp is trading slightly higher in pre-market hours, recovering from a decline in the previous session amid broader tech stock volatility.

29 iul. 2026, 19:36 UTC

Correlated Moves

Macro Event

Twist Bioscience shares are lower today, influenced by a declining Russell 2000 Index and persistent inflation concerns amid steady interest rates.

28 iul. 2026, 21:56 UTC

Twist Bioscience Corp shares are trading lower in after-market hours. Broader market trends, including declines in Asian semiconductor stocks, may be influencing this movement.

27 iul. 2026, 19:33 UTC

Twist Bioscience Corp shares are lower today, continuing a recent downward trend. The stock pulled back significantly after reaching a session high.

24 iul. 2026, 15:24 UTC

Twist Bioscience Corp shares are lower today, reversing a recent trend of gains. High trading volume accompanies the decline amid mixed economic signals.

21 iul. 2026, 20:02 UTC

Correlated Moves

Twist Bioscience Corp is advancing today, supported by high trading volume and renewed investor interest in technology and AI stocks, despite a pullback earlier in the session.

20 iul. 2026, 23:06 UTC

Twist Bioscience Corp shares are higher in after-market trading, though no specific news was identified to explain the movement. The stock remains below its 20-day moving average.

Comparație

Modificare preț

Twist Bioscience Corp Așteptări

Obiectiv de preț

By TipRanks

-4.46% jos

Prognoză pe 12 luni

Medie 109.88 USD -4.46%

Maxim 120 USD

Minim 95 USD

În baza a 9 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruTwist Bioscience Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

9 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 9 analiști care au acordat evaluări ale acțiunilor Twist Bioscience Corp - Dist în ultimele 3 luni.

Sentiment

By Acuity

306 / 340 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Twist Bioscience Corp

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.